Journal for ImmunoTherapy of Cancer (Nov 2020)

359 AMG 757, a half-life extended bispecific T-cell engager (BiTE®) immune therapy against DLL3 in SCLC: phase 1 interim results

  • Hui Yang,
  • Stephane Champiat,
  • Ramaswamy Govindan,
  • Ravi Salgia,
  • Fiona Blackhall,
  • Everett Vokes,
  • Michael Boyer,
  • Marie-Anne Damiette Smit,
  • Melissa Johnson,
  • Hossein Borghaei,
  • Luis Paz-Ares Rodrigues,
  • Rene Boosman,
  • Horst-Dieter Hummel,
  • W Victoria Lai,
  • Hibiki Udagawa,
  • Anne Chiang,
  • Christine Hann,
  • Mukul Minocha,
  • Nooshin Hashemi-Sadraei,
  • Aditya Shetty,
  • Taofeek Owonikoko

DOI
https://doi.org/10.1136/jitc-2020-SITC2020.0359
Journal volume & issue
Vol. 8, no. Suppl 3

Abstract

Read online

No abstracts available.